Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study

Front Pharmacol. 2023 Jun 27:14:1185850. doi: 10.3389/fphar.2023.1185850. eCollection 2023.

Abstract

Background: Although oxidative stress is known to contribute to cancer, and endogenous and exogenous antioxidants are thought to prevent tumorigenesis by suppressing oxidative stress-induced DNA damage, antioxidants have also been reported to show negative effects on tumor formation, necessitating characterization of the causal associations between antioxidants and cancer risk. Methods: In this study, Mendelian randomization (MR) analysis, primarily inverse-variance weighted MR, was used to assess the causal effect of six endogenous and five exogenous diet-derived antioxidants on the risk of six cancers. MR-Egger intercept test and Cochran's Q statistic were utilized to assess pleiotropy and heterogeneity, respectively. Results: For endogenous antioxidants, a bidirectional two-sample MR analysis was conducted. Our findings suggested that serum albumin has a negative causal association with the risk of prostate cancer [odds ratio (OR) = 0.78, 95% confidence interval (CI): 0.68-0.91, p = 0.001]. The risks of the six cancers showed no significant associations with endogenous antioxidants in the converse MR analysis. For exogenous antioxidants, the unidirectional two-sample MR analysis exhibited a nominal relationship between the serum retinol level and non-small-cell lung cancer risk (OR = 0.29, 95% CI: 0.11-0.76, p = 0.011). Conclusions: Thus, our study revealed the protective effects of genetic susceptibility to high circulating albumin levels on prostate cancer, providing potential targeted interventions for prostate cancer prevention.

Keywords: Mendelian randomization study; cancer prevention; endogenous antioxidant; exogenous antioxidant; oxidative stress.

Grants and funding

This work was supported by the National Natural Science Foundation of China (grant no. U20A20376), Beijing Award Foundation, (grant no. YXJL-2020-0818-0478), Heilongjiang Province Postdoctoral Science Foundation (grant no. LBHZ21189), Harbin Medical University Innovative Science Research Funded Project (grant no. 2022-KYYWF-0289), China Postdoctoral Science Foundation (grant no. 2022MD713747), Gusu Health Talent Program (GSWS2020067).